Personalized Medicine, Bioethics and Social Responsibilities: Re-thinking the Pharmaceutical Industry to Remedy Inequities in Patient Care and International Health

Publisher： Bentham Science Publishers

E-ISSN： 1875-6913|6|2|108-120

ISSN： 1875-6921

Source： Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.6, Iss.2, 2008-06, pp. : 108-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bilski: Assessing the Impact of a Newly Invigorated Patent-Eligibility Doctrine on the Pharmaceutical Industry and the Future of Personalized Medicine

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 18, 2010-12 ,pp. : 1937-1949

Bentham Science Publishers

Access to resources Recommend Favorite

Personalized Medicine and Breast Cancer Care

By Burstein Harold J.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 2, 2009-02 ,pp. : 109-109

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Rethinking Pharmacogenomics Education Beyond Health Professionals: Addressing the “Know-Do” Gap Across the Personalized Medicine Innovation Ecosystem

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 4, 2012-12 ,pp. : 277-287

Bentham Science Publishers

Access to resources Recommend Favorite

The potential and limitations of personalized medicine in the doctor–patient relationship

By Hapgood Rhydian  

Pharmacogenomics, Vol. 4, Iss. 6, 2003-11 ,pp. : 685-687

Future Medicine

Access to resources Recommend Favorite

Health Economics in the Canadian Pharmaceutical Industry

By Assiff L.  

PharmacoEconomics, Vol. 16, Iss. 6, 1999-12 ,pp. : 669-678

Adis International

Access to resources Recommend Favorite